Autoimmune Disease Diagnostics Market Size

Autoimmune Disease Diagnostics Market Size

Autoimmune Disease Diagnostics Market size was valued at USD 5.3 billion in 2023 and is anticipated to witness growth at a CAGR of 5.9% between 2024 and 2032. The rising incidence of autoimmune diseases and the adoption of automation in equipment are vital factors propelling global market growth.

Autoimmune disorders develop when the immune system mistakenly attacks its own cells due to abnormalities. A failure to detect immune cells, tissues, and organs, coupled with the production of autoantibodies targeting these cells, causes the immune system to malfunction. Consequently, several initiatives by organizations aim to raise awareness about autoimmune diseases and their socioeconomic impact, thereby increasing the usage rates of autoimmune disease diagnostics globally. Additionally, improved laboratory automation and technological advancements in diagnostics are driving the expansion of the autoimmune disease diagnostics market.
 

Autoimmune diseases are conditions where the immune system attacks one or more normally functioning cells in the body due to asymmetry or irregularities. This malfunction is primarily caused by the immune system's inability to recognize tissues, immunological cells, and other organs, leading to the production of autoantibodies against these cells.
 

However, the need for high capital investment in setting up diagnostic centers, slow turnaround times for test results, and the requirement for multiple diagnostic tests can adversely affect market growth. Diagnostic centers for autoimmune diseases face stringent government regulations and diagnostic complications that may negatively impact business expansion. Various blood tests, such as C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), enzyme-linked immunosorbent assay (ELISA), and rheumatoid factor (RF), are used to detect the type and severity of autoimmune diseases.